Skip to main content

New Products

  • Dr. Reddy's launches generic acne drug

    HYDERABAD, India — Dr. Reddy's has launched a drug for treating acne, the company said Friday.

    The Indian generic drug maker announced the launch of Zenatane (isotretinoin) capsules in the 20-mg and 40-mg strengths. The drug is a therapeutically equivalent generic version of Roche's Accutane. The Food and Drug Administration also approved the drug in the 10-mg strength.

    Various versions of the drug had sales of about $309 million during the 12-month period that ended in January, according to IMS Health.

     

  • Reports: Walmart considers customer-to-customer delivery service

    BENTONVILLE, Ark. — As Reuters reported yesterday, Walmart is considering a new delivery system that would have in-store customers deliver packages to online buyers. The delivering customers would receive a discount off their shopping bills.

  • Houston dermatologist develops new shave gel for women

    NEW YORK — Looking to jazz up the shave market, Milton Moore, a Houston-based dermatologist and founder of Moore Unique Skin Care, has expanded his product portfolio with the new Silky Hydroglide Shave Gel and Post Shave Rejuvenation for Women.

    Moore’s latest venture is a product that promises to provide the following user benefits:

    • Lubricates, moisturizes and treats dry and irritated skin for the closest nick-free shave possible;

    • Dermatologist developed and designed specifically for women;

  • Vitamin Squeeze offers powdered water enhancers

    PHOENIX — Vitamin Squeeze announced today the release of a full line of powdered water enhancers available in supermarkets nationwide.

    Vitamin Squeeze Powder Water Enhancers come in eight flavors and three varieties:

    • Multi-Vitamin (Fruit Punch, Acai Grape Pomegranate, Strawberry Watermelon and Lemonade);

    • Energy (Black Cherry, Blood Orange and Blueberry Pomegranate Acai); and

  • Medicare dashboard advances ACA goals for chronic conditions

    WASHINGTON — A new Medicare Chronic Conditions Dashboard announced today by Marilyn Tavenner, acting administrator of the Centers for Medicare and Medicaid Services (CMS), furthers the Patient Protection and Affordable Care Act’s goals for health promotion and the prevention and management of multiple chronic conditions.

  • FDA approves J&J diabetes drug

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Johnson & Johnson for treating Type 2 diabetes, the agency said.

    The FDA announced the approval of J&J subsidiary Janssen Pharmaceuticals' Invokana (canagliflozin) tablets, designed for use with diet and exercise to improve blood-sugar control in adults with the disease.

  • HHS updates HIPAA rules for electronic health records

    NEW YORK — The Department of Health and Human Services issued a new rule that it said was necessary to protect the security of health information stored online.

    As required by the Health Information Technology for Economic and Clinical Health Act, which was part of the 2009 economic stimulus bill, HHS said it would change patient privacy rules in the Health Insurance Portability and Accountability Act in order to provide for privacy and security protection for information stored in electronic health records.

  • Reese launches first product under new 'Old School' brand

    CLEVELAND — Reese Pharmaceutical on Thursday announced the development of its Old School brand, which will feature products that have been used for generations. The first offering in the new line will be Reese’s Old School Charcoal Capsules, a dietary supplement for the relief of intestinal gas and flatulence.  

    The main ingredient, activated charcoal, is a highly recognized, proven remedy that adsorbs the toxins that cause flatus and gas, reducing after-meal discomfort. 

X
This ad will auto-close in 10 seconds